Taro Pharmaceutical Industries (TARO) Earnings Date, Estimates & Call Transcripts → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free TARO Stock Alerts $42.30 +0.10 (+0.24%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMay. 20Confirmed Get Taro Pharmaceutical Industries Earnings AlertsEnter your email address below to receive the latest news and earnings results for TARO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTARO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TARO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Taro Pharmaceutical Industries Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.31$0.31$0.31Q2 20241$0.18$0.18$0.18Q3 20241$0.30$0.30$0.30Q4 20241$0.31$0.31$0.31FY 20244$1.10$1.10$1.10TARO Earnings Date and InformationTaro Pharmaceutical Industries has confirmed that its next quarterly earnings report will be published on Monday, May 20th, 2024. Read More Taro Pharmaceutical Industries Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/20/2024Confirmed)------- 1/25/2024Q3 2024$0.30$0.56+$0.26$0.58$154.90 million$157.15 million10/26/2023Q2 2024$0.18$0.38+$0.20$0.53$161.14 million$148.20 million7/26/2023Q1 2024$0.31$0.40+$0.09$0.53$149.00 million$158.89 million5/23/2023Q4 2023$0.23$0.18($0.05)$0.18$150.69 million$146.59 million1/24/2023Q3 2023$0.87$0.19($0.68)$0.19$163.12 million$139.20 million10/27/2022Q2 2023$0.84($0.07)($0.91)($0.07)$161.02 million$130.50 million Get the Latest News and Ratings for TARO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Taro Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 7/27/2022Q1 2023$0.85$0.37($0.48)$0.37$149.90 million$156.67 million5/26/2022Q4 2022$0.88$0.73($0.15)$0.73$147.00 million$143.26 million1/27/2022Q3 2022-$0.70+$0.70$0.70-$138.98 million 10/28/2021Q3 2021$1.02$0.66($0.36)$0.70$153.23 million$131.99 million7/27/2021Q2 2021$0.84$1.09+$0.25$2.68$137.20 million$147.11 million Taro Pharmaceutical Industries Earnings - Frequently Asked Questions When is Taro Pharmaceutical Industries's earnings date? Taro Pharmaceutical Industries has confirmed that its next quarterly earnings data will be published on Monday, May 20th, 2024. Learn more on TARO's earnings history. How much revenue does Taro Pharmaceutical Industries generate each year? Taro Pharmaceutical Industries (NYSE:TARO) has a recorded annual revenue of $572.95 million. How much profit does Taro Pharmaceutical Industries generate each year? Taro Pharmaceutical Industries (NYSE:TARO) has a recorded net income of $25.44 million. TARO has generated $1.22 earnings per share over the last four quarters. What is Taro Pharmaceutical Industries's price-to-earnings ratio? Taro Pharmaceutical Industries (NYSE:TARO) has a trailing price-to-earnings ratio of 34.67 and a forward price-to-earnings ratio of 30.65. More Earnings Resources from MarketBeat Related Companies: SUPN Earnings Date KURA Earnings Date SYRE Earnings Date RCUS Earnings Date EWTX Earnings Date LGND Earnings Date GPCR Earnings Date SDGR Earnings Date HRMY Earnings Date AVDL Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NYSE:TARO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taro Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
